Literature DB >> 21912251

Recent insights into the mechanism of transfusion-related acute lung injury.

Ulrich J Sachs1.   

Abstract

PURPOSE OF REVIEW: This review summarizes the recent clinical and experimental literature on the pathogenesis of transfusion-related acute lung injury (TRALI), with a focus on mechanistic aspects. RECENT
FINDINGS: Mechanisms by which leukocyte antibodies induce TRALI have been unraveled, including a multistep cascade for HLA class II-induced TRALI. Significant advances have also been made in the field of recipient-related factors that contribute to the development of TRALI, both in clinical and animal studies. In contrast, TRALI associated with the transfusion of blood components that do not contain antibodies is an emerging problem, especially because the relevance of mechanisms proposed earlier is questioned by the recent findings. New mechanisms need yet to be defined. The diversity of newly described factors contributing to TRALI demonstrates that a two-hit model falls too short to explain this complex syndrome and rather supports the previously proposed threshold model of TRALI.
SUMMARY: Activated neutrophils are central in the pathophysiology of TRALI as their interaction with the lung endothelium causes capillary leak and pulmonary edema. Typically, numerous factors must act together in order to overcome a critical activation threshold of the neutrophil. At least one of these factors originates from a transfused blood component.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21912251     DOI: 10.1097/MOH.0b013e32834bab01

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  10 in total

1.  Storage of Red Blood Cells and Transfusion-Related Acute Lung Injury.

Authors:  Arkady Babaev; Federico Pozzi; Gregory Hare; Haibo Zhang
Journal:  J Anesth Crit Care       Date:  2014-01-01

2.  Recognition, Investigation and Management of Acute Transfusion Reactions: Consensus guidelines for Oman.

Authors:  Arwa Z Al-Riyami; Sabria Al-Hashmi; Zainab Al-Arimi; Louis D Wadsworth; Abdulhakim Al-Rawas; Murtadha Al-Khabori; Shahina Daar
Journal:  Sultan Qaboos Univ Med J       Date:  2014-07-24

Review 3.  Anemia, red blood cell transfusions, and necrotizing enterocolitis.

Authors:  Akhil Maheshwari; Ravi M Patel; Robert D Christensen
Journal:  Semin Pediatr Surg       Date:  2017-11-06       Impact factor: 2.754

Review 4.  Association between red cell transfusions and necrotizing enterocolitis.

Authors:  Sachin C Amin; Juan I Remon; Girish C Subbarao; Akhil Maheshwari
Journal:  J Matern Fetal Neonatal Med       Date:  2012-10

Review 5.  Epidemiology of Necrotizing Enterocolitis: New Considerations Regarding the Influence of Red Blood Cell Transfusions and Anemia.

Authors:  Vivek Saroha; Cassandra D Josephson; Ravi Mangal Patel
Journal:  Clin Perinatol       Date:  2018-12-12       Impact factor: 3.430

6.  Human neutrophil antigen-3a antibodies induce neutrophil aggregation in a plasma-free medium.

Authors:  Nicole Schubert; Tom Berthold; Stefan Muschter; Jan Wesche; Birgitt Fürll; Angelika Reil; Jürgen Bux; Tamam Bakchoul; Andreas Greinacher
Journal:  Blood Transfus       Date:  2013-07-11       Impact factor: 3.443

7.  Transfusion-Related Acute Lung Injury: The Work of DAMPs.

Authors:  Walter G Land
Journal:  Transfus Med Hemother       Date:  2013-01-03       Impact factor: 3.747

Review 8.  Adverse effects of plasma transfusion.

Authors:  Suchitra Pandey; Girish N Vyas
Journal:  Transfusion       Date:  2012-05       Impact factor: 3.157

Review 9.  Transfusion-related acute lung injury; clinical perspectives.

Authors:  Jeongmin Kim; Sungwon Na
Journal:  Korean J Anesthesiol       Date:  2015-03-30

10.  Dexmedetomidine Improves Lung Function by Promoting Inflammation Resolution in Patients Undergoing Totally Thoracoscopic Cardiac Surgery.

Authors:  Junji Cui; Mintai Gao; Hongqian Huang; Xiaoyan Huang; Qingshi Zeng
Journal:  Oxid Med Cell Longev       Date:  2020-09-07       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.